Webcast: Pills and CEOs Under Fire as M&A Fades
The Deal and its expert panel discuss increased scrutiny on executive pay, poison pills and other measures taken to defend against activist campaigns.
Mergers & Acquisitions
Up-to-the-minute alerts and analytical intelligence focused on potential and announced transactions as well as the people behind them.
M&A Intelligence
News From The Deal
Drinks With The Deal: Dechert's Ken Young
Dechert's Ken Young discusses how PE firms have diversified, the challenges of partner development and his recent deals.
Webcast: SPACs are Back
The Deal and its panel of experts discuss the proliferation of SPACs in the IPO market and whether this trend will continue as the economy rebounds.
